drugset / Trial / NCT00945932

A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics

NCT00945932

Phase 2 Completed 37 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study will measure the effect of repeat inhaled doses of GW870086X on lung function.

Timeline

Start
2009-07
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GW870086 Small molecule 1 mg Inhaled

Indications